Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anxiety Disorders

Trial Information

Cipralex® for Anxiety Disorders in Adolescents

Official Title: Cipralex® for Anxiety Disorders in Adolescents: Clinical and Physiological Changes Associated With Open Label, Flexible-dose Treatment

Summary

The primary objective is to examine whether Cipralex® is effective and safe in the treatment of anxiety disorders in youth. The secondary objective is to identify changes in arousal and stress response from pre- to post-treatment with Cipralex® in youth with anxiety disorders.

Phase: Phase 1

Sponsor: University of Ottawa

Overall Contacts:

Martine Flament, MD
613-722-6521 ext. 6455

Chantelle McEwen, MA
Phone: 613-722-6521 ext. 6194

Locations (1)

Country State City Zip Facility and Contact
Canada Ontario Ottawa K1Z 7K4 The University of Ottawa Institute of Mental Health Research
Chantelle McEwen, MA
613-722-6521 ext. 6194
chantelle.mcewen@rohcg.on.ca

Martine Flament, MD
Principal Investigator

NCT ID:NCT01293838

Date Last Changed: February 10, 2011